Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferrochelatase pseudogene 1 (FECHP1)
- Target
- FECHP1
- Molecular classification
- Pseudogene, Processed pseudogene
01
Overview
Ferrochelatase pseudogene 1 (FECHP1) is a processed pseudogene located at human chromosome 3p22-p23, closely related in nucleotide sequence (>80% identity) to the functional ferrochelatase gene (FECH) but lacking intronic regions and containing multiple genetic disruptions that prevent protein expression. It does not encode a functional polypeptide, is not transcribed in detectable amounts in erythroid cells, and is not involved in heme biosynthesis. Its main significance is in genetic studies related to ferrochelatase deficiency and heme biosynthesis disorders, where it may complicate gene mapping or mutation detection efforts. No direct disease roles, biological functions, or drug interactions are established.
02
Mechanism of action
None; no drugs target this pseudogene.
03
Biological functions
No direct encoded biological function; does not produce a protein or participate in enzymatic or signaling pathwaysPossible regulatory roles by acting as a decoy for microRNAs (miRNA decoy/ceRNA effect), as suggested for other pseudogenes, but no firm evidence for FECHP1 specifically
04
Disease associations
Not directly involved in disease, but may have practical implications for molecular analysis of diseases such as erythropoietic protoporphyria by complicating gene mapping or mutation analysisNo evidence of pathological or therapeutic relevance
05
Safety considerations
None; there are no safety concerns or therapeutic challenges related to FECHP1, as it is nonfunctional.
Beyond the preview
Go deeper on Ferrochelatase pseudogene 1 (FECHP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ferrochelatase pseudogene 1 (FECHP1).